{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:29:23Z","timestamp":1761514163295},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1097\/md.0000000000009854","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T21:16:48Z","timestamp":1519852608000},"page":"e9854","source":"Crossref","is-referenced-by-count":7,"title":["The clinical characteristics and the features of immunophenotype of peripheral lymphocytes of adult onset chronic active Epstein-Barr virus disease at a Tertiary Care Hospital in Beijing"],"prefix":"10.1097","volume":"97","author":[{"given":"Ling","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-43-20210226","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med"},{"key":"R2-43-20210226","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MOH.0b013e32834daa08","article-title":"Current diagnosis and management of infectious mononucleosis","volume":"19","author":"Vouloumanou","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"R3-43-20210226","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"key":"R4-43-20210226","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann Oncol"},{"key":"R5-43-20210226","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1182\/blood-2002-01-0039","article-title":"Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection","volume":"100","author":"Savoldo","year":"2002","journal-title":"Blood"},{"key":"R6-43-20210226","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/367988","article-title":"Prognostic factors for chronic active Epstein-Barr virus infection","volume":"187","author":"Kimura","year":"2003","journal-title":"J Infec Dis"},{"key":"R7-43-20210226","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen","year":"2011","journal-title":"Blood"},{"key":"R8-43-20210226","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.20398","article-title":"Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection","volume":"80","author":"Okano","year":"2005","journal-title":"Am J Hematol"},{"key":"R9-43-20210226","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R10-43-20210226","first-page":"455","article-title":"An analysis of immunophenotyping of peripheral lymphocytes in adult patients with infectious mononucleosis and chronic active Epstein-Barr virus infection","volume":"55","author":"Xie","year":"2016","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"R11-43-20210226","first-page":"36","article-title":"The correlation between HLA-DR or CD38 expression in CD8(+) T cells and CD4(+) T cells count in treatment-naive HIV\/AIDS patients","volume":"55","author":"Xie","year":"2016","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"R12-43-20210226","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00246-008-9343-8","article-title":"Cardiovascular complications associated with chronic active Epstein-Barr virus infection","volume":"30","author":"Muneuchi","year":"2009","journal-title":"Pediatr Cardiol"},{"key":"R13-43-20210226","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jiac.2015.11.002","article-title":"Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein-Barr virus disease","volume":"22","author":"Ito","year":"2016","journal-title":"J Infect Chemother"},{"key":"R14-43-20210226","first-page":"307","article-title":"Quantification of Epstein-Barr virus DNA is helpful for evaluation of chronic active Epstein-Barr virus infection","volume":"227","author":"Sakamoto","year":"2012","journal-title":"J Exp Med"},{"key":"R15-43-20210226","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V96.2.443","article-title":"Fulminant EBV (+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome","volume":"96","author":"Quintanilla-Martinez","year":"2000","journal-title":"Blood"},{"key":"R16-43-20210226","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3760\/cma.j.issn.0366-6999.2009.03.005","article-title":"Clinical analysis and follow-up study of chronic active Epstein-Barr virus infection in 53 pediatric cases","volume":"122","author":"Lu Gen","year":"2009","journal-title":"Chin Med J"},{"key":"R17-43-20210226","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/427239","article-title":"Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection","volume":"191","author":"Kimura","year":"2005","journal-title":"J Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000009854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T17:23:35Z","timestamp":1719854615000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201803020-00043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000009854","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}